Health Care & Life Sciences » Pharmaceuticals | Abbott India Ltd.

Abbott India Ltd. | Mutual Funds

Mutual Funds that own Abbott India Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Franklin India High Growth Companies Fund
395,000
1.86%
-15,000
4.17%
08/31/2018
Reliance Pharma Fund
218,279
1.03%
0
6.96%
08/31/2018
GS Funds - India Equity Portfolio
179,602
0.85%
-5,385
0.82%
06/30/2018
L&T Mid Cap Fund
84,200
0.4%
0
2.23%
07/31/2018
L&T Emerging Businesses Fund
81,000
0.38%
81,000
1.25%
07/31/2018
Kotak Emerging Equity Scheme
64,608
0.3%
0
1.59%
07/31/2018
GS Funds - Growth & Emerging Markets Broad Equity Portfolio
61,790
0.28%
0
0.22%
06/30/2018
Reliance Growth Fund
57,023
0.27%
0
0.68%
08/31/2018
Motilal Oswal MOSt Focused 25 Fund
34,926
0.16%
0
2.49%
08/31/2018
Eaton Vance Greater India Portfolio
34,365
0.16%
-551
1.6%
06/30/2018

About Abbott India

View Profile
Address
16th Floor, Godrej BKC
Mumbai Maharashtra 400051
India
Employees -
Website http://www.abbott.co.in
Updated 09/14/2018
Abbott India Ltd. is a pharmaceutical company, which develops, manufactures and markets pharmaceutical, diagnostic, nutritional, and hospital products. Its products include ebasil, solspre, citrosoda, digenewas, actnew, acuvin, and acevah. The company was founded on August 22, 1944 and is headquartered in Mumbai, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.